A Study of mRNA-1010 Compared With a Licensed Influenza Vaccine in Adults ≥50 Years of Age

NCT06602024 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

40817

Enrollment

INDUSTRY

Sponsor class

Conditions

Seasonal Influenza

Interventions

BIOLOGICAL: mRNA-1010
BIOLOGICAL: Fluarix®
BIOLOGICAL: Influsplit® Tetra
BIOLOGICAL: Fluarix Tetra
BIOLOGICAL: Alpharix® Tetra

Sponsor

ModernaTX, Inc.